Skip to main content
. 2022 May 25;2022:5769555. doi: 10.1155/2022/5769555

Table 4.

Overall therapeutic outcome (clinical cure, microbiological cure, and therapeutic cure in both groups).

Variables Bacterial vaginosis Candidiasis Cervicitis uPID
Groups AG PG AG PG AG PG AG PG
No. of Pt 7(100) 6(100) 0 1(100) 22(100) 22(100) 7(100) 14(100)
Clinical cure
Colour of discharge
D0 White 7(100) 4(66.6) 0 1(100) 4(66.6) 6(27.27) 2(28.57) 4(28.57)
Greyish 0(0) 0 15(68.18) 14(63.63) 2(28.57) 6(42.85)
Yellowish 0(0) 2(33.33) 3(13.63) 2(9.09) 3(42.85) 4(28.57)
Greenish 0(0) 0(0) 0(0) 0(0) 0(0) 0(0)
D11-14 Responded 7(100) 0 0 0 17(77.27) 0 5(71.42) 0
Odour of discharge
D0 No-smell 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0)
Foul-smell 7(100) 0(0) 1(100) 19(86.36) 21(95.45) 5(71.42) 8(57.14)
Fishy 0(0) 6(100) 3(13.63) 1(4.54) 2(28.57) 6(42.85)
D11-14 Responded 7(100) 0 0 0 20(90.90) 0 7(100) 0
Amount of discharge
D0 Present 7(100) 6(100) 1(100) 22(100) 22(100) 7(100) 14(100)
D11-14 Responded 7(100) 0 0 10(45.45) 0 5(71.42) 0
D0 Ut. motion tenderness 17(77.27) 18(81.81) 7(100) 14(100)
D11-14 Responded 10(58.82) 0 5(71.42) 0
D0 McPS 7(100) 14(100)
D11 Responded 5(71.42) 0
Microbiological and investigational cure (vaginal smear, pH, pap smear)
D0 pH > 4.5 6(85.7) 5(83.33)
D11-14 Responded 6(100) 0
D0 Clue cells 7(100) 6(100)
Hyphae 1(100)
Pus cells >10 22(100) 21 (95.45) 6(85.71) 13(92.8)
D11-14 Responded 7(100) 0 0 13(59.09) 0 6 7(100)
D0 Whiff test 7(100) 6(100) 7(100)
D11-14 Responded 7(100) 0 7(100)
D0 Pap smear 7(100) 6(100) - 1(100) 22(100) 22(100) 7(100)
D11-14 Responded 7(100) 0 10(45.45) 0 7(100)
Therapeutic cure 7(100) 0 0 0 10(45.45) 0 5(71.42) 0

Data presented were as follows: no (%); AG : Acacia group; PG : placebo group; McPS : Modified McCormack Pain Scale; Pt : patient; uPID (uncomplicated pelvic inflammatory disease)